logo

For the Inventor, By the Inventor

La Jolla, CA, United States of America

Sanford-burnham Medical Research Institute


USPTO Granted Patents = 99



Forward Citations = 287

Loading Chart...
Loading Chart...

165 inventors (with patents filed for the assignee):

goldMedal Erkki I Ruoslahti (27 out of 133 patents)

silverMedal John C Reed (17 out of 85 patents)

bronzeMedal Nicholas D P Cosford (7 out of 10 patents)

4.  Tambet Teesalu (6 out of 13 patents)

5.  Kazuki Sugahara (6 out of 10 patents)

6.  Anthony B Pinkerton (6 out of 42 patents)

7.  Adam Godzik (6 out of 16 patents)

8.  Stuart Arthur Lipton (5 out of 27 patents)

9.  Jiwen Zou (4 out of 9 patents)

10.  Jose Luis Millan (4 out of 7 patents)

11.  Lianglin Zhang (4 out of 6 patents)

12.  Douglas Hanahan (4 out of 10 patents)

13.  Maurizio Pellecchia (4 out of 24 patents)

14.  Robert J Ardecky (4 out of 32 patents)

15.  Michiko N Fukuda (4 out of 16 patents)


Core Competencies:
Digestive Health
Peptides and Proteins
Apoptotic Pathway
Quinazolinone Analogs
Endometriosis Treatment
Metabotropic Glutamate Receptors
Stem Cell Differentiation
HIV Replication Inhibitors
Tumor Targeting
Inflammatory Disorders
Cardiomyocyte Contraction
Nanoparticle Delivery

99 patents:

1. 11382880 - Method for improving digestive health (2022-07-12),
2. 11260133 - Methods and compositions related to peptides and proteins with C-terminal elements (2022-03-01),
3. 11059718 - Methods and compositions using peptides and proteins with C-terminal elements (2021-07-13),
4. 10787439 - Compounds and methods for activating the apoptotic arm of the unfolded protein response (2020-09-29),
5. 10611733 - Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections (2020-04-07),
6. 10370245 - Methods and compositions using peptides and proteins with C-terminal elements (2019-08-06),
7. 10259844 - Endometriosis cell targeting peptide and uses thereof (2019-04-16),
8. 10227561 - Methods and compositions for targeting progenitor cell lines (2019-03-12),
9. 10179801 - Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides (2019-01-15),
10. 10099993 - Metabotropic glutamate receptor positive allosteric modulators (PAMS) and uses thereof (2018-10-16),
11. 10047119 - Inhibitor of apoptosis protein (IAP) antagonists (2018-08-14),
12. 10039838 - Car peptide for homing, diagnosis and targeted therapy for pulmonary and fibrotic disorders (2018-08-07),
13. 10001622 - Multifunction autofocus system and method for automated microscopy (2018-06-19),
14. 10001470 - Method, system and composition for optically inducing cardiomyocyte contraction (2018-06-19),
15. 9994915 - miR-211 expression and related pathways in human melanoma (2018-06-12),
Sanford-Burnham Medical Research Institute is a non-profit medical research institute dedicated to discovering the fundamental mechanisms of human biology and identifying new therapeutic approaches to improve human health. With a focus on collaborative research, the Institute brings together scientists from various disciplines to tackle some of the most challenging diseases and conditions, such as cancer, diabetes, neurodegenerative diseases, and infectious diseases.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

99 Patents

#7 in La Jolla, CA

#866 in California

#3,674 in US

#7,622 in the World

...
La Jolla, CA, United States of America

Sanford-burnham Medical Research Institute

Forward Citations = 287

165 inventors:

goldMedal Erkki I Ruoslahti (27 out of 133 patents)

silverMedal John C Reed (17 out of 85 patents)

bronzeMedal Nicholas D P Cosford (7 out of 10 patents)

4.  Tambet Teesalu (6 out of 13 patents)

5.  Kazuki Sugahara (6 out of 10 patents)

Please report any incorrect information to support@idiyas.com
Loading…